IMVT INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Announces Investigation into a Private Placement Transaction by Immunovant, Inc. and Encourages Investors to Contact the Firm Robbins ...

In this article, we are going to take a look at where Immunovant, Inc. (NASDAQ:IMVT) stands against the other stocks that will bounce back. Major US indexes finished in the green on Wednesday ...

Myasthenia gravis is an autoimmune disorder in which antibodies disrupt the communication between nerves and muscles, ...

The FDA has approved Johnson & Johnson's anti-FcRn antibody, nipocalimab, for the treatment of generalized myasthenia gravis. The drug will be sold under the brand name IMAAVY. This approval ...

Recent findings regarding interferon and Janus kinase inhibition may hold clues to improving outcomes in patients with ...

Dr. Torti also formerly worked at Sio Gene Therapies, Inc., as Chairman from 2018 to 2023, Immunovant, Inc., as Chairman, Arbutus Biopharma Corp., as Chairman from 2018 to 2025, NeoTract ...

At close: May 21 at 4:00:01 PM EDT ...